Prospects for site-specific delivery of pharmacologic and molecular therapies

Journal of the American College of Cardiology

Volumn 23, Issue 5, 1994, Pages 1234-1244

  Riessen, Reimer ^a   Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PHOTOSENSITIZING AGENT; RECOMBINANT PROTEIN;

CORONARY ARTERY OBSTRUCTION; DRUG DELIVERY SYSTEM; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECOMBINANT GENE; REVIEW; VASCULAR DISEASE;

BALLOON DILATATION; BLOOD VESSELS; CARDIOVASCULAR AGENTS; CELL DIVISION; DRUG DELIVERY SYSTEMS; GENE THERAPY; HEART CATHETERIZATION; HUMAN; MUSCLE, SMOOTH, VASCULAR; PHOTOCHEMOTHERAPY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028231256     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)90616-5     Document Type: Review

References (107)

1. Syndromes of accelerated atherosclerosis role of vascular injury and smooth muscle cell proliferation
2. Migration of smooth muscle and endothelial cells. Critical events in restenosis
3. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms
4. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty
5. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization
6. Novel drug and device combinations for targeted prevention of restenosis
7. Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase
8. Femoral artery recanalisation with percutaneous angioplasty and segmentally enclosed plasminogen activator
9. Site-specific gene expression in vivo by direct gene transfer into the arterial wall
10. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo
11. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery
12. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter
13. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter
14. Local drug delivery catheters: functional comparison of porous and microporous designs
15. Use of a porous infusion balloon in swine coronary arteries: tew pressure minimizes arterial pressure [abstract]
16. Effects of local delivery of doxorubicin or saline on restenosis following angioplasty in atherosclerotic rabbits (abstract)
17. Local infusion balloon angioplasty to obviate restenosis compared with conventional balloon angioplasty in an experimental model of atherosclerosis
18. Gene transfer into intact porcine coronary arteries via infusion balloon catheter: influences of delivery volume and pressure [abstract]
19. A new PTCA balloon catheter with intramural channels for local delivery of drugs at low pressure [abstract]
20. Enhanced localization and retention of microparticles following intramural delivery into atherosclerotic arteries using a new delivery device [abstract]
21. Localized intramural delivery of a marker agent during balloon angioplasty: a new technique using hydrogel coated balloons and active diffusion
22. Arterial gene transfer using pure DNA applied directly to a hydrogelcoated angioplasty balloon
23. Method of application of local high dose heparin during balloon angioplasty [abstract]
24. Transdermal delivery of drugs by iontophoresis a review
25. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy
26. Intravascular local delivery: an iontophoretic approach [abstract]
27. Seeding of intravascular stents with genetically engineered endothelial cells
28. Polymeric stents: modern alchemy or the future?
29. Bioabsorbable, drug-eluting intracoronary stents: design and future applications
30. Short and long-term vascular tissue response to the Duke bioabsorbable stent [abstract]
31. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents
32. Differential arterial response to stents in a porcine coronary model; exogenous fibrin vs Polyurethane vs polyethylene terephthalate [abstract]
33. A new method for arterial drug delivery via removable stent [abstract]
34. Localized intramural delivery of heparin during balloon angioplasty a new technique using heparin-coated balloons and active diffusion [abstract]
35. Local heparin delivery with a hydrogel-coated PTCA balloon catheter inhibits platelet-dependent thrombosis [abstract]
36. Effect of chronic subcutaneous or intramural administration of heparin on femoral artery restenosis after balloon angioplasty in hypercholesterdemic rabbits. A quantitative angiographic and histopathological study
37. Effect of local delivery of heparin and methotrexate on neointimal proliferation in stented porcine coronary arteries
38. Serial assessment of heparin coating on vascular responses to a new tantalum stent [abstract]
39. Inhibition of intimal wall thickening by porous balloon catheter delivery of low molecular weight heparin (abstract)
40. The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit
41. Restenosis in an atherosclerotic rabbit model is reduced by a thiol protease inhibitor [abstract]
42. Efficacy of local intramural injection of colchicine in reducing restenosis following angioplasty in the atherosclerotic rabbit model [abstract]
43. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty
44. Effect of controlled adventitial heparin delivery on smooth muscle proliferation following endothelial injury
45. Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation
46. Local anticoagulation without systemic effect using a polymer heparin delivery system
47. Local delivery of dexamethasone for prevention of neointimal proliferation after balloon injury in the rat carotid model [abstract]
48. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty
49. Biodegradable microspheres containing a colchicine analog inhibit DNA synthesis in vascular smooth muscle cells [abstract]
50. Local delivery of biodegradable microparticles containing colchicine or colchicine analog does not block restenosis in atherosclerotic rabbit femoral arteries [abstract]
51. Local treatment of intracoronary thrombus and thrombotic abrupt closure following failed coronary angioplasty with urokinase-coated hydrogel balloons [abstract]
52. Systemic gene expression after intravenous DNA delivery into adult mice
53. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors
54. Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy
55. Time course of human growth hormone secretion following arterial gene transfer: a model for vascular gene therapy [abstract]
56. Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis
57. Recombinant fibroblast growth factor-I promotes intimal hyperplasia and angiogenesis in arteries in vivo
58. Conditioned inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
59. In vivo evidence of enhanced angiogenesis following direct arterial gene transfer of the plasmid encoding vascular endolhelial growth factor [abstract]
60. Gene transfer in the treatment of thrombosis
61. Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral-mediated gene transfer
62. High-level expression of recombinant human tPA in cultivated canine endothelial cells under varying conditions of retroviral gene transfer
63. Expression of an anchored urokinase in the apical endothelial cell membrane
64. Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries
65. Liposome-mediated gene transfer into human vascular smooth muscle cells
66. ™ reagent: a new, higher efficiency polycationic liposome transfection reagent
67. The basic science of gene therapy
68. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
69. Increased gene expression following liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury
70. Widespread long-term gene transfer to mouse skeletal muscles and heart
71. Recombinant adenovirus is an efficient vector for in vivo gene transfer and can be preferentially directed at vascular endothelium or smooth muscle cells [abstract]
72. Local delivery of adenovirus for percutaneous arterial gene transfer. A comparison of double and hydrogel-coated balloons [abstract]
73. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries
74. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice
75. Adenovirus vectors enter the brain
76. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
77. Novel and effective gene transfer technique for study of vascular renin angiotensin system
78. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles
79. Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes
80. Gene transfer into established and primary fibroblast cell lines: comparison of transfection methods and promoters
81. Recombinant gene expression in vivo within endothelial cells of the arterial wall
82. Introduction of vascular smooth muscle cells expressing recombinant genes in vivo
83. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen
84. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro
85. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration
86. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells
87. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
88. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia
89. Phototherapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder
90. Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative
91. Responses of cultured smooth muscle cells from human nonatherosclerotic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses
92. Application of photodynamic therapy to the treatment of atherosclerotic plaques
93. Pathological effects of balloon Xe-Hg flash lamp irradiation as photodynamic therapy for the prevention of restenosis [abstract]
94. Laser balloon angioplasty clinical angiographic and histologic results
95. Comparison of intracellular and extracellular mitogenic activity
96. Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration
97. Photodynamic therapy of arteries. A novel approach for the treatment of experimental intimal hyperplasia
98. Chloroaluminum sulfonated phthalocyanine partitioning in normal and intimal hyperplastic artery in the rat. Implications for photodynamic therapy
99. 8-Methoxypsoralen and long wave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle
100. Low dose sub-ablative ultraviolet (UV-C) laser irradiation from a Q-switched, frequency-quadrupled Nd:YLF diode laser inhibits neointimal hyperplasia in balloon-injured rat carotid arteries [abstract]
101. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells
102. Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptor
103. In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells
104. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors
105. Lymphocyte/monocyte interleukin-2 receptor targeted fusion toxin therapy with DAB486-IL2 prevents proliferative post-angioplasty restenosis [abstract]
106. Inhibition of injury-induced intimal thickening in the rat carotid artery by a recombinant cytotoxin specific for the epidermal growth factor receptor [abstract]
107. Local and systemic delivery of DAB389EGF fusion toxin inhibits neointimal thickening in balloon-injured rat carotids [abstract]